Clinical Trial Update: Effect of UDCA on the New Onset Diabetes and Glucose Intolerance Induced by Statin [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial investigating UDCA for preventing or treating statin-induced new-onset diabetes and glucose intolerance.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Drugs mentioned

• UDCA (ursodeoxycholic acid)

Snippet

Sponsor: First Affiliated Hospital Xi'an Jiaotong University | Conditions: Diabetes Mellitus | Phase 2, Phase 3 | Status: UNKNOWN